Short Interest in iShares Health Innovation Active ETF (NYSEARCA:BMED) Rises By 42.2%

iShares Health Innovation Active ETF (NYSEARCA:BMED) was the target of a large growth in short interest in the month of January. As of January 15th, there was short interest totaling 6,335 shares, a growth of 42.2% from the December 31st total of 4,455 shares. Based on an average trading volume of 4,774 shares, the short-interest ratio is presently 1.3 days. Approximately 2.6% of the shares of the company are short sold. Approximately 2.6% of the shares of the company are short sold. Based on an average trading volume of 4,774 shares, the short-interest ratio is presently 1.3 days.

iShares Health Innovation Active ETF Stock Down 0.7%

NYSEARCA BMED opened at $31.08 on Friday. The company has a market cap of $7.46 million, a PE ratio of 24.91 and a beta of 0.84. iShares Health Innovation Active ETF has a 52 week low of $20.57 and a 52 week high of $32.19. The firm’s 50-day simple moving average is $30.82 and its two-hundred day simple moving average is $28.22.

iShares Health Innovation Active ETF Company Profile

The BlackRock Future Health ETF (BMED) is an exchange-traded fund that is based on the MSCI All Country World index. The fund is actively managed to invest in global equities in the health sciences industry. BMED was launched on Sep 29, 2020 and is managed by BlackRock.